These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1373230)

  • 1. The prevalence of antibody to hepatitis C virus in a dialysis population.
    Hay NM; Lynn KL; Schousboe MI
    N Z Med J; 1992 Apr; 105(931):134. PubMed ID: 1373230
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis-C virus (HCV) in peritoneal dialysis.
    Krautzig S; Tillmann H; Wrenger E; Manns M; Koch KM; Brunkhorst R
    Clin Nephrol; 1994 Feb; 41(2):120. PubMed ID: 7516274
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C antibody in renal transplant patients.
    Klauser R; Franz M; Traindl O; Pidlich J; Hay U; Watschinger B; Pohanka E; Kovarik J
    Transplant Proc; 1992 Feb; 24(1):286-8. PubMed ID: 1371619
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Lee HY; Kang DH; Park CS; Kim KY; Kang SW; Kim HS; Choi KH; Ha SK; Han DS
    Yonsei Med J; 1993 Dec; 34(4):371-80. PubMed ID: 7510444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus in dialysis patients in Spain. Spanish Multicentre Study Group.
    Nephrol Dial Transplant; 1995; 10 Suppl 6():78-80. PubMed ID: 8524503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
    Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
    Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of hepatitis C virus antibodies in chronic hemodialysis and kidney transplantation patients].
    Castillo L; Díaz P; Inostroza J; Espinoza R; Millaqueo L; Calderara M; Pinto A; Behrens C; Pereira O
    Rev Med Chil; 1993 Sep; 121(9):1024-8. PubMed ID: 7514806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antihepatitis C antibodies in patients treated with continuous ambulatory peritoneal dialysis and hemodialysis.
    Pérez-Fontán M; Moncalián J; Rodríguez-Carmona A; Arrojo F
    Nephron; 1991; 58(3):381-2. PubMed ID: 1654529
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.
    Ponz E; Campistol JM; Barrera JM; Gil C; Pinto J; Andreu J; Bruguera M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1371-2. PubMed ID: 1846466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C virus antibodies in persons on dialysis].
    Pazdiora P; Herynková R; Opatrný K; Veselá E; Benesová J; Vlasák J; Vodrázková Z; Holá R; Kubátová A; Hájek V
    Cas Lek Cesk; 1993 Apr; 132(8):243-5. PubMed ID: 7508340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transmission of hepatitis C virus by dialysis: myth or reality? New perspective with molecular studies].
    Alvarado Esquivel C
    Rev Invest Clin; 2001; 53(1):13-4. PubMed ID: 11332044
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
    Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
    Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.